Infection Control

• PAT/IC 2 – Asplenic Patients Policy – Management of Patients with Absent or Dysfunctional Spleen
• PAT/IC 4  – Variant Creutzfeldt-Jakob Disease (vCJD) and Transmissible Spongiform Encephalopathy Agents (TSE): Minimising the Risks of Transmission
• PAT/IC 5   – Hand Hygiene
• PAT/IC 6  – MRSA Screening and Management of Patients with MRSA
• PAT/IC 7  – Scabies – Guidance on Management
• PAT/IC 8  – Sharps Policy – Safe Use and Disposal
• PAT/IC 10  – Management of Respiratory Type Viruses
• PAT/IC 11  – Pathology Specimens – Collection and Handling of Pathology Specimens
• PAT/IC 12  – Meningococcal Infections – Management of Cases and Contacts
• PAT/IC 14 – Management  of Sharps Injuries and Blood and Body Fluid Exposure Incidents
• PAT/IC 15 – Chickenpox/Shingles Management Policy
• PAT/IC 16 – Isolation Policy
• PAT/IC 17  – Management of Patients with Glycopeptide Resistant Enterococci
• PAT/IC 18 – Spillage of Blood and Other Body Fluids
• PAT/IC 19  – Standard Infection Prevention and Control Precautions Policy
• PAT/IC 20  – Management and Control of Incident/Outbreak of Infection
• PAT/IC 22 – Kitchen Hygiene and Refrigerator Monitoring Policy for Wards and Clinical Areas
• PAT/IC 23 – Tuberculosis – Care of the Patient with Pulmonary or Laryngeal Tuberculosis in Hospital
• PAT /IC 24 – Cleaning and Disinfection of Ward-based Equipment
• PAT/IC 26 – Clostridioides difficile Infection (CDI) Policy
• PAT/IC 27  – Gastroenteritis Minor Outbreak Policy (Diarrhoea and Vomiting)
• PAT/IC 28 – Multi-Resistant Gram-Negative Bacteria (in particular CPE) Prevention and Control Policy
• PAT/IC 31  – Surveillance Policy
• PAT/IC 32  – Hazard Group 4 Viral Haemorrhagic Fevers
• PAT/IC 33 – Animals on Trust Premises (Including Pets As Therapy)
• PAT/IC 34 – Faecal Microbiota Transplantation Policy – Use of Faecal Microbiota Transplantation (FMT) in the management of Clostridioides difficile infection
• To access the Trust Antibiotic Formulary please click here

---